STOCK TITAN

Boston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2021 Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Boston Scientific Corporation (NYSE: BSX) will participate in the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 8:15 a.m. EST. CEO Mike Mahoney, CFO Dan Brennan, and VP Lauren Tengler will present and engage in Q&A. Additionally, a conference call to discuss the fourth quarter financial results for 2021 will be held on February 2, 2022, at 8:00 a.m. EST. The financial results will be announced prior to the call. Both events will be accessible via webcast at investors.bostonscientific.com.

Positive
  • None.
Negative
  • None.

MARLBOROUGH, Mass., Jan. 4, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022. Mike Mahoney, chairman and chief executive officer, will present at ­­­8:15 a.m. EST. Mahoney will be joined by Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor Relations, in a question-and-answer session with the host analyst.

On Wednesday February 2, 2022 Boston Scientific will webcast its conference call discussing financial results and business highlights for the fourth quarter ended December 31, 2021. The call will begin at 8:00 a.m. EST, hosted by Mike Mahoney and Dan Brennan. The company will issue a news release announcing financial results for the fourth quarter on February 2 prior to the conference call.

A live webcast and replay of the webcast for each event will be accessible at investors.bostonscientific.com. The replay will be available approximately one hour following the completion of each event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS


Media:

Investors:

Kate Haranis

Lauren Tengler

508-683-6585 (office)

508-683-4479 (office)

Media Relations

Investor Relations

Boston Scientific Corporation

Boston Scientific Corporation

Kate.Haranis@bsci.com

BSXInvestorRelations@bsci.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-jp-morgan-healthcare-conference-and-announces-conference-call-discussing-fourth-quarter-2021-results-301452818.html

SOURCE Boston Scientific Corporation

FAQ

What is the date and time of BSX's presentation at the J.P. Morgan Healthcare Conference?

Boston Scientific's presentation is scheduled for January 12, 2022, at 8:15 a.m. EST.

Who will represent BSX at the J.P. Morgan Healthcare Conference?

CEO Mike Mahoney, CFO Dan Brennan, and VP Lauren Tengler will represent Boston Scientific.

When is the Boston Scientific conference call for fourth quarter 2021 results?

The conference call is set for February 2, 2022, at 8:00 a.m. EST.

What will be discussed in the Boston Scientific conference call on February 2, 2022?

The call will discuss the financial results and business highlights for the fourth quarter ended December 31, 2021.

How can I access the BSX events via webcast?

Both events will be accessible at investors.bostonscientific.com after the events.

Boston Scientific Corp.

NYSE:BSX

BSX Rankings

BSX Latest News

BSX Stock Data

129.09B
1.47B
0.18%
93.1%
0.77%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
MARLBOROUGH